BGC focuses on merchant banking and investing opportunities in Greater China. We can assist your company in meeting its corporate objectives if you are:

A North America or Europe based company

• Interested in outsourcing to Greater China
• Interested in entering the Chinese market
• Seeking strategic partnerships with Chinese companies
• Seeking cross-border M&A opportunities

A Chinese company

• Seeking to in-license overseas products or technologies
• Interested in forming a strategic alliance with overseas companies
• Seeking cross-border M&A opportunities
• Interested in entering the overseas markets

Top Challenges Faced by Biopharmaceutical Companies	How China Strategies can Provide the Solution
High drug development cost >$1 billion for each successfully developed drug	Outsource to China Pre-clinical drug development ~20% U.S. cost
High attrition rate in new drug development <1% success rate from preclinical to NDA approval	Accelerated first in man POC in China More “shots on goal” with early elimination of unacceptable drug candidates
Fierce market competition Need to capture value for drugs outside U.S. and Europe	Technology transfer to China Capture large market of unmet needs
Need top line growth Increasing cost of drug development and pressure from healthcare provider to lower price	China expansion China pharmaceutical market to become top 5 by 2010

BGC Serves as Your Transaction Partner for Your Cross-Border Transactions

By providing strategic guidance, extensive business acumen and network as well as financial expertise, BGC's goal is to be your transaction partner to maximize the value your company can garner from each transaction. BGC is uniquely positioned to enable bidirectional technology transfer between North American, European and Asian companies and low-cost outsourcing from North America and Europe to Asia. We expertly and effectively "bridge" life science resources between North America, Europe and Asia.

BGC Serves as Your "Cross-Cultural Bridge"

BGC has deep business and cultural experience in both China and the West. Understanding that successful businesses can only be built with the knowledge of local markets and access to local resources, the team has established a strong network of Chinese life science leaders. The team can help you to overcome the cultural barriers and communicational difficulties involved in cross-Pacific business.

BGC Builds on Strong Foundation of Scientific and Industrial Experience

The BGC team provides you with a rare combination of strong business acumen and broad technical expertise. The core team, Jonathan Wang and Benjamin Chen, are both Chinese born professionals with advanced scientific training and extensive business experience. We understand our clients' technology and business, and provide strategic advice to our clients to help them achieve their strategic objectives.

BGC Leverages the Vast Network and Resources of Burrill & Company

BGC is an integral part of Burrill & Company and is supported by the firm's extensive resources and network. Burrill & Company, with a staff of over 50 professionals, is assisted by 17 large corporate partners, 36 world-class advisors and 25 financial partners. The Burrill & Company merchant banking practice has extensive experience in strategic partnering, M&A and the provision of strategic advice. The group has completed transactions with a total value of over $1.5 billion. BGC leverages this know-how in order to assist clients conduct businesses related to Greater China.